University Health Network, Toronto: all 1,432 studies
Page 15 of 15. Open to participants first (292), then studies with results posted, then the rest; newest registration first within each.
- Dexamethasone Study: Impact on Quality of Life of Continuing Dexamethasone Following Emetogenic ChemotherapyCompletedNCT00152867Phase 3
- Acetaminophen for Cancer PainCompletedNCT00152854Phase 3
- Effect of Iron and Vitamin E Supplementation on Disease Activity in Patients With Either Crohn's Disease or Ulcerative ColitisTerminatedNCT00152841Phase 2
- Celebrex - Cervix: Celecoxib in the Treatment of Patients With Locally Advanced Carcinoma of the CervixCompletedNCT00152828Phase 1/2
- Pneumonia Vaccine in Liver Transplant Recipients: a Booster Strategy Using a Conjugate VaccineStatus unknownNCT00152802Phase 4
- Normal Prostate: Oxygenation of the Prostate Gland in Men Undergoing Prostate BiopsyCompletedNCT00152789Phase 2
- Study of Clonidine on Sleep Architecture in Children With Tourette's Syndrome (TS) and Comorbid ADHDStatus unknownNCT00152750Phase 4
- RCT of a Group Intervention for Women With a Family History of Breast CancerCompletedNCT00150917Phase 3
- Diet and Breast Cancer Prevention TrialCompletedNCT00148057Phase 3
- Identification of the Genetic Variants Responsible for Primary Biliary Cirrhosis (PBC)Status unknownNCT00145964
- Pneumonia Vaccine in Bone Marrow Transplant Recipients: Usefulness of Donor VaccinationCompletedNCT00143780Phase 4
- Toronto Bedside Swallowing Screening Test (TOR-BSST) - A Bedside Swallowing Screening for Stroke PatientsCompletedNCT00141752
- Tuberculosis (TB) Screening for the Diagnosis of Latent TB in Immunocompromised PopulationsCompletedNCT00134342
- Sorafenib and Erlotinib in Treating Patients With Metastatic or Unresectable Solid TumorsCompletedNCT00126620Phase 1
- Vorinostat and Capecitabine in Treating Patients With Metastatic or Unresectable Solid TumorsCompletedNCT00121277Phase 1
- Tipifarnib, Cytarabine, and Daunorubicin in Treating Older Patients With Acute Myeloid LeukemiaCompletedNCT00101153Phase 1
- GTI-2040, Docetaxel, and Prednisone in Treating Patients With Prostate CancerCompletedNCT00087165Phase 2
- 3-AP and Gemcitabine in Treating Patients With Recurrent, Unresectable, or Metastatic Pancreatic CancerCompletedNCT00078975Phase 2
- UCN-01 and Topotecan in Treating Patients With Recurrent, Persistent, or Progressive Advanced Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube CancerCompletedNCT00072267Phase 2
- Bortezomib in Treating Patients With Advanced or Metastatic Transitional Cell Cancer of the Bladder, Renal Pelvis, or UreterCompletedNCT00066352Phase 2
- Perifosine in Treating Patients With Recurrent, Refractory, Locally Advanced, or Metastatic Breast CancerCompletedNCT00054145Phase 2
- Perifosine in Treating Patients With Advanced Pancreatic CancerCompletedNCT00053924Phase 2
- Bortezomib in Treating Patients With Metastatic or Recurrent Colorectal CancerCompletedNCT00052507Phase 2
- Combination Chemotherapy and Imatinib Mesylate in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00052494Phase 1
- Oblimersen and Doxorubicin in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)CompletedNCT00047229Phase 2
- Tipifarnib in Treating Patients With Recurrent Bladder CancerCompletedNCT00047216Phase 2
- Imatinib Mesylate in Treating Patients With Salivary Gland CancerCompletedNCT00045669Phase 2
- Combination Chemotherapy in Treating Patients With Chronic Lymphocytic Leukemia or Lymphocytic LymphomaCompletedNCT00045513Phase 1/2
- UCN-01 and Topotecan in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity CancerCompletedNCT00045175Phase 1
- Erlotinib and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck CancerCompletedNCT00030576Phase 1/2
- Angioplasty and Heart Stents to Treat Individuals With an Occluded Artery Following a Heart AttackCompletedNCT00025766Phase 4
- EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue SarcomaTerminatedNCT00004261Phase 1
← University Health Network, Toronto overview and focus areas